Serial Optical Coherence Tomography Assessment of Plaque Phenotype Stabilization after Paclitaxel-Coated Balloon Treatment in De Novo Coronary Lesions.

摘要

PURPOSE: There is limited evidence regarding serial plaque changes after paclitaxel-coated balloon (PCB) treatment in de novo coronary target lesions assessed using optical coherence tomography (OCT). MATERIALS AND METHODS: A prospective serial OCT was performed on de novo target lesions in 48 patients (50 lesions) who underwent PCB treatment. Follow-up OCT was conducted for all lesions after a median of 6 months. The primary analysis evaluated changes in minimum fibrous cap thickness and maximum lipid arc across the imaged lesion segment. RESULTS: In 2550 matched cross-sections from the analyzed lesions, the minimum fibrous cap thickness increased from 40.0±15.1 µm to 46.6±15.7 µm (p=0.007), and the maximum lipid arc decreased from 297.8±68.1° to 252.6±76.3° (p<0.001). The prevalence of thin-cap fibroatheroma (TCFA) decreased from 24.8% to 17.4% (p<0.001), and macrophage presence declined from 87.0% to 83.1% (p=0.001). At the lesion level, mean lumen area increased from 4.2±2.7 mm² to 6.6±3.1 mm², and minimum lumen area increased from 1.8±0.9 mm² to 4.9±2.1 mm² (both p<0.001). At the plaque level, 24 of 37 TCFA plaques at baseline changed to non-TCFA morphology (64.9%), while four of 40 non-TCFA plaques progressed to TCFA (10%). CONCLUSION: At 6 months after PCB treatment, target-lesion plaques exhibited OCT-derived changes consistent with a shift toward a less vulnerable plaque phenotype. The clinical implications of these imaging findings require further investigation.